- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02418715
Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women
Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women: A Randomized Controlled Trial
The aim of this study was to investigate the effects of water-based exercises on lipid profile (LP) and lipoprotein lipase (LPL) levels in premenopausal dyslipidemic women.
It was hypothesized that a water-based aerobic interval-training period would decrease plasma concentrations of atherogenic lipoproteins and concomitantly increase HDL and LPL levels, as well as maximal oxygen uptake (VO2max) values.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Premenopausal
- Sedentary
- Dyslipidemic
- Aged between 40 and 50 years old
Exclusion Criteria:
- Smokers
- Hypolipemic drugs users
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Water Aerobics Training
The training period was composed by a 12-week macrocycle with two sessions per week.
The macrocycle was divided into three four-week mesocycles that were, in turn, divided into four one-week microcycles composed by two training sessions.
Each training session took 45 min.
Nine different water-aerobics exercises were used during the training period.
These exercises were performed alternating the right and left limbs.
Exercise intensities were controlled using the Borg Scale.
Interval training was used alternating intensities ranged between 9 (easy) and 15 (hard).
During the first mesocycle, participants performed sets of 3min at intensity 13 interspersed by 2min at intensity 9; during the second mesocycle, sets of 3min at intensity 15 followed by 2min at intensity 9 were performed; finally, sessions of the third mesocycle were composed by sets of 3min at intensity 15 followed by 2min at intensity 11.
|
Other Names:
|
No Intervention: Control
No training, no intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Lipid Profile Levels (total cholesterol, LDL, HDL, triglycerides)
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Lipoprotein Lipase Levels
Time Frame: 12 weeks
|
12 weeks
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Maximal oxygen uptake (VO2max) values
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Water-Based Exercise Trial
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyslipidemia
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemia (Fredrickson Type Ⅱa) | Dyslipidemia (Fredrickson Type Ⅱb)Korea, Republic of
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
Yooyoung Pharmaceutical Co., Ltd.CompletedCombined DyslipidemiaKorea, Republic of
-
Société des Produits Nestlé (SPN)CompletedPrimary DyslipidemiaChina
-
Provident Clinical ResearchReliant PharmaceuticalsUnknown
-
Hanlim Pharm. Co., Ltd.RecruitingMixed DyslipidemiaKorea, Republic of
-
IlDong Pharmaceutical Co LtdNot yet recruiting
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Provident Clinical ResearchReliant PharmaceuticalsCompleted
Clinical Trials on Water Aerobics Training
-
Hospital de Clinicas de Porto AlegreCompleted
-
Fundació Sant Joan de DéuParc Sanitari Sant Joan de Déu; Solidaritat Sant Joan de Déu; FluidraRecruiting
-
Professor Fernando Figueira Integral Medicine InstituteCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...CompletedDiabetes, GestationalBrazil
-
Professor Fernando Figueira Integral Medicine InstituteConselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de...Completed
-
Biruni UniversityNot yet recruiting
-
Riphah International UniversityCompletedDiabetic Peripheral NeuropathyPakistan
-
Federal University of São PauloCompleted
-
Muhammad IrfanRecruitingPolycystic Ovary SyndromePakistan
-
Merit UniversityCompletedCorona Virus InfectionEgypt
-
Federal University of PelotasCompleted